logo
  

EARNINGS SUMMARY: Details of Nektar Therapeutics Q3 Earnings Report

Below are the earnings highlights for Nektar Therapeutics (NKTR):

-Earnings: -$108.57 million in Q3 vs. -$98.59 million in the same period last year.
-EPS: -$0.61 in Q3 vs. -$0.56 in the same period last year.
-Analysts projected -$0.74 per share
-Revenue: $30.03 million in Q3 vs. $29.22 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT